Bromadiolone and Flocoumafen concentrations tended to be higher in the group of patients with bleeding or INR > 5 (p 0.06), and significantly higher in the group with major subcutaneous bleeding (p 0.012 and p 0.027 respectively in Bromadiolone and Flocoumafen).